Travere Therapeutics, Inc., announced that the Company will present 11 abstracts, including one late-breaking abstract at the upcoming American Society of Nephrology (ASN) Kidney Week 2024 in San Diego, CA, October 23-27,… read more.
AstraZeneca will share new data across its Vaccines & Immune Therapies portfolio at the 13th annual IDWeek in Los Angeles, California, from 16-19 October 2024. The Company will highlight… read more.
Plus Therapeutics, a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, will have multiple opportunities to present data at the… read more.
Merck, known as MSD outside of the United States and Canada, announced upcoming data presentations and programming at the 25th International AIDS Conference (AIDS 2024), taking place July 22-26,… read more.
ASHP Midyear Clinical Meeting – Highlights In November 2023 The Pharmacy Technician Society (TPTS) was launched under the wing of The American Society for Health System Pharmacists (ASHP)…. read more.
Following a severe stroke caused by artery-blocking clots, patients who undergo endovascular therapy (mechanical clot removal) plus standard medical therapy have fewer physical limitations 90 days post-stroke compared… read more.
Teleflex Incorporated announced that new real-world healthcare claims data reveal that the risk of return procedures is lowest after treatment with the UroLift System among the analyzed benign… read more.
Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
